@xconomy.com 2 months ago
Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue
@xconomy.com 1 year ago
ASH 2018: A Guide to the Latest for Blood-Borne Cancers and More
@xconomy.com 2 years ago
Bio Roundup: BIO Diversity, Allogene IPO, CRISPR In Utero & More
@xconomy.com 2 years ago
Six Life Science Firms Close Q3 with an IPO, More Are on the Way